Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Dow
Cantor Fitzgerald
Harvard Business School
Queensland Health
Cipla
US Army
AstraZeneca
Argus Health
Covington

Generated: August 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: 1,4-Dihydropyridine derivatives
Abstract:There are provided novel 1,4-dihydropyridine derivatives, particularly 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino)ethyl ester and 5-methyl ester. The 1,4-dihydropyridine derivatives are characterized by cerebral vascular dilator activity.
Inventor(s): Murakami; Masuo (Tokyo, JA), Takahashi; Kozo (Tokyo, JA), Iwanami; Masaru (Yokohama, JA), Fujimoto; Masaharu (Tokyo, JA), Shibanuma; Tadao (Asaka, JA), Kawai; Ryutaro (Shiraoka, JA), Takenaka; Toichi (Tokyo, JA)
Assignee: Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JA)
Application Number:05/584,268
Patent Claims: 1. A compound of the formula ##SPC10##

wherein R represents hydrogen or lower alkyl; R.sup.1 and R.sup.2 each represents methyl; R.sup.3 represents phenyl, benzyl, halobenzyl, lower alkoxy-benzyl; R.sup.4 represents hydrogen, methyl or ethyl; A represents lower alkylene; R.sup.5 represents methyl, or lower alkoxy, or lower alkoxy substituted with lower alkoxy, or ##EQU1## in which R.sup.3 and R.sup.4 have the same meaning as above; and R.sup.6 represents nitro or trifluoromethyl.

2. The 1,4-dihydropyridine compound as claimed in claim 1 wherein said R is hydrogen, said R.sup.1 and R.sup.2 each represents methyl; said R.sup.3 represents benzyl; said R.sup.4 represents methyl or ethyl; said R.sup.5 represents lower alkoxy; and said R.sup.6 represents nitro.

3. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino ethyl ester 5-methyl ester.

4. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) ethyl ester 5-ethyl ester.

5. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) ethyl ester 5-isopropyl ester.

6. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-ethylamino) ethyl ester 5-isopropyl ester.

7. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) propyl ester 5-isopropyl ester.

8. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-p-methoxybenzyl-N-methylamino) ethyl ester 5-ethyl ester.

9. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-p-chlorobenzyl-N-methylamino) ethyl ester 5-ethyl ester.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Cantor Fitzgerald
Covington
Fuji
Novartis
Merck
McKinsey
UBS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot